Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 451

1.

Leuprolide acetate depot and hormonal add-back in endometriosis: a 12-month study. Lupron Add-Back Study Group.

Hornstein MD, Surrey ES, Weisberg GW, Casino LA.

Obstet Gynecol. 1998 Jan;91(1):16-24.

PMID:
9464714
2.

Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up.

Surrey ES, Hornstein MD.

Obstet Gynecol. 2002 May;99(5 Pt 1):709-19.

PMID:
11978277
4.

Subcutaneous injection of depot medroxyprogesterone acetate compared with leuprolide acetate in the treatment of endometriosis-associated pain.

Schlaff WD, Carson SA, Luciano A, Ross D, Bergqvist A.

Fertil Steril. 2006 Feb;85(2):314-25.

PMID:
16595206
5.
6.

Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.

Gregoriou O, Konidaris S, Vitoratos N, Papadias C, Papoulias I, Chryssicopoulos A.

Int J Fertil Womens Med. 1997 Nov-Dec;42(6):406-11.

PMID:
9459084
7.

Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.

Regidor PA, Regidor M, Schmidt M, Ruwe B, Lübben G, Förtig P, Kienle E, Schindler AE.

Gynecol Endocrinol. 2001 Jun;15(3):202-9.

PMID:
11447732
8.
9.
10.

Dose effects of progesterone in add-back therapy during GnRHa treatment.

Cheung TH, Lo KW, Yim SF, Lam C, Lau E, Haines C.

J Reprod Med. 2005 Jan;50(1):35-40.

PMID:
15730171
13.

Add-back therapy in the treatment of endometriosis-associated pain.

Zupi E, Marconi D, Sbracia M, Zullo F, De Vivo B, Exacustos C, Sorrenti G.

Fertil Steril. 2004 Nov;82(5):1303-8.

PMID:
15533351
14.

Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis: A Randomized Controlled Trial.

DiVasta AD, Feldman HA, Sadler Gallagher J, Stokes NA, Laufer MR, Hornstein MD, Gordon CM.

Obstet Gynecol. 2015 Sep;126(3):617-27. doi: 10.1097/AOG.0000000000000964.

16.

Add-back therapy use and its impact on LA persistence in patients with endometriosis.

Fuldeore MJ, Marx SE, Chwalisz K, Smeeding JE, Brook RA.

Curr Med Res Opin. 2010 Mar;26(3):729-36. doi: 10.1185/03007990903582985.

PMID:
20092387
17.

One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis: a randomized double-blind trial.

Fernandez H, Lucas C, Hédon B, Meyer JL, Mayenga JM, Roux C.

Hum Reprod. 2004 Jun;19(6):1465-71. Epub 2004 Apr 22.

PMID:
15105403
18.

Can we decrease breakthrough bleeding in patients with endometriosis on norethindrone acetate?

Muneyyirci-Delale O, Jalou S, Rahman M, Nacharaju V.

Int J Fertil Womens Med. 2003 Jan-Feb;48(1):32-6.

PMID:
12643518
19.

[Conservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosis].

Zhou J, Lei ZW, Lü JQ, Sun J, Xu XW.

Zhonghua Fu Chan Ke Za Zhi. 2005 Jan;40(1):5-8. Chinese.

PMID:
15774083
20.

Supplemental Content

Support Center